We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+19.59%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$64.9M
AUM Growth
+$20.6M
Cap. Flow
+$15M
Cap. Flow %
23.18%
Top 10 Hldgs %
77.5%
Holding
29
New
8
Increased
6
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$2.26M
2
OR icon
OR Royalties Inc
OR
+$2.22M
3
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
+$1.2M
4
SILV
SilverCrest Metals Inc. Common Shares
SILV
+$1.04M
5
NOC icon
Northrop Grumman
NOC
+$1M

Top Sells

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$1.23M
2
BX icon
Blackstone
BX
+$742K

Sector Composition

Rank Sector Weight
1 Healthcare 65.57%
2 Materials 6.74%
3 Industrials 3.4%
4 Financials 1.69%
5 Consumer Staples 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVDL
26
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-150,000
Closed -$1.23M
BX icon
27
Blackstone
BX
$110B
– –
-10,000
Closed -$742K
1
2

Similar funds

FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return

Knoll Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Knoll Capital Management held 29 positions worth $64.9M, up 46% from $44.3M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Knoll Capital Management deployed $15M of net new capital in Q1 2023, opening 8 new positions and adding to 6 existing holdings. Its largest new stake was Omega Therapeutics, Inc. Common Stock: 173,010 shares worth $1.04M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 69% a quarter earlier, followed by Materials and Industrials.

On the sell side, the most notable exit was Avadel Pharmaceuticals, an estimated $1.23M sold.

  • Knoll Capital Management's largest Q1 2023 buy was Omega Therapeutics, Inc. Common Stock: 173,010 shares worth $1.04M.
  • Knoll Capital Management added most to Verona Pharma in Q1 2023, an estimated $2.26M increase.
  • Knoll Capital Management fully exited Avadel Pharmaceuticals in Q1 2023, selling an estimated $1.23M.
  • Knoll Capital Management's ten largest holdings make up 77% of its $64.9M portfolio in Q1 2023.
  • Knoll Capital Management opened 8 new positions and closed 3 in Q1 2023.
  • Knoll Capital Management's portfolio value rose 46% quarter-over-quarter to $64.9M.

Based on Knoll Capital Management's 13F filing for Q1 2023, filed 15 May 2023.